N-glycosylation profiling of Type 2 diabetes mellitus from baseline to follow-up: an observational study in a Ghanaian population

Biomark Med. 2021 May;15(7):467-480. doi: 10.2217/bmm-2020-0615. Epub 2021 Apr 15.

Abstract

Aim: The study sought to determine the patterns of N-glycan profiles among Type 2 diabetes mellitus (T2DM) patients over a 6-month period. Materials & methods: Biochemical and clinical data were obtained from 253 T2DM patients at baseline and follow-up. Ultra-performance liquid chromatography and statistical methods were applied for N-glycan profiling. Results: The coefficients of variation were 28% and 29% at baseline and follow-up, respectively, whereas the range of N-glycan variability was from 11% to 56%. Apart from GP1 (FA2) and GP29 (FA3G3S [3,3,3]3), the intra-individual variations of N-glycan peaks were not statistically significant. Conclusion: N-glycan profiles were stable over 6-month period in T2DM patients and could be used to monitor biochemical changes in relation with T2DM comorbidities.

Keywords: N-glycans; Type 2 diabetes mellitus; biomarker; stability; ultra-performance liquid chromatography.

Publication types

  • Observational Study

MeSH terms

  • Biomarkers / blood
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetes Mellitus, Type 2 / pathology
  • Female
  • Follow-Up Studies
  • Ghana / epidemiology
  • Glycosylation
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Polysaccharides / blood*
  • Prognosis

Substances

  • Biomarkers
  • Polysaccharides